Press Releases

10/06 Sensorion Achieves Key Regulatory Milestones for SENS-601 for GJB2-related Hearing Loss and Selects Program as Lead Gene Therapy Candidate BU
18/05 Sensorion : Inside Information / Other news releases PU
18/05 Sensorion Appoints Fred Chereau as Chief Executive Officer BU
13/05 Sensorion : Inside Information / Other news releases PU
13/05 Sensorion Publishes Results of Combined Shareholders’ General Meeting Resolutions BU
05/05 Sensorion Announces its Participation in the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting BU
22/04 Sensorion Provides Preliminary Documents for the Combined Shareholders General Meeting of May 11, 2026 AQ
21/04 Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 11, 2026 BU
23/03 Sensorion : Inside Information / Other news releases PU
23/03 Sensorion Reports Six-Month Update from the Audiogene Phase 1/2 Trial of SENS-501 and Advances GJB2-GT (SENS-601) Toward First-in-Human Clinical Development BU
18/03 Sensorion : Inside Information / News release on accounts, results PU
18/03 Sensorion Reports Full-Year 2025 Results, Provides Corporate Update and Announces Release of Annual Report BU
17/02 Sensorion Announces Leadership Changes BU
06/02 Sensorion : Inside Information / Other news releases PU
06/02 Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 49th Annual Midwinter Meeting BU
30/01 Sensorion Announces EUR60 Million Financing with a EUR20M Strategic Investment from Sanofi and Support from Global Healthcare Specialists to Advance Genetic Medicine Pipeline AQ
28/01 Sensorion : Inside Information / Other news releases PU
28/01 Sensorion Announces €60 Million Financing With a €20M Strategic Investment from Sanofi and Support from Global Healthcare Specialists To Advance Genetic Medicine Pipeline BU
19/12 Sensorion to Present at the 44th Annual J.P. Morgan Healthcare Conference BU
08/12 Sensorion Reports Independent Data Monitoring Committee Raises No Safety Concerns and Agrees to Continue SENS-501’s Audiogene Phase 1/2 Trial BU
17/09/25 Sensorion Reports 2025 Half-Year Results, Provides Corporate Update and Announces Availability of Half-Year Report BU
04/09/25 Sensorion Announces its Participation in the 60th Annual Inner Ear Biology Workshop BU
15/08/25 Sensorion : Informations privilégiées / Autres communiqués PU
15/08/25 Sensorion Announces an Increase in Resources Allocated to the Liquidity Contract with Kepler Cheuvreux BU
31/07/25 Sensorion Announces Its Participation In Upcoming Investor Conferences BU
No results match your criteria
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!